Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonapanitase in Radiocephalic AVF Creation
NCT02414841Phase 3Completed
- Sponsor
- Proteon Therapeutics
- Start
- Aug 2015
- Primary completion
- Feb 2018
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of vonapanitase in chronic kidney disease (CKD), sponsored by Proteon Therapeutics. Started Aug 2015; status: completed.
02
Drugs
vonapanitase
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02414841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414841.